BRITISH AMERICAN TOBACCO (NGP) LIMITED

British American Tobacco (NGP) Limited acts as an investment holding company in subsidiary undertakings of the British American Tobacco p.l.c. group of companies. The company is committed to researching, developing and promoting a range of innovative tobacco and nicotine products to enable adult consumers to have a choice of less risky alternatives to regular cigarettes. They launched Vype, an e-cigarette, in the UK in 2013 and have further increased their understanding of consumer needs. They are also looking at nicotine products that are regulated as medicines, including a new nicotine inhalation product called Voke, licensed as a medicine in the UK. The company also has plans to have their first tobacco heating product in a test market in 2016.